Are laboratory tests necessary to confirm menopause and if so, what tests are recommended?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Laboratory tests are generally not necessary to confirm menopause in most women, but in certain situations, such as women under 45 with menopausal symptoms or those with unclear symptoms, blood tests like follicle-stimulating hormone (FSH) and estradiol may be recommended. Menopause is typically diagnosed based on clinical symptoms and the absence of menstrual periods for 12 consecutive months in women over age 45 1. The definition of menopause includes a profound and permanent decrease in ovarian estrogen synthesis, and reasonable criteria for determining menopause include prior bilateral oophorectomy, age ≥60 years, or age <60 years and amenorrheic for 12 or more months with FSH and estradiol in the postmenopausal range 1.

Key Considerations for Laboratory Testing

  • FSH and estradiol levels can help confirm menopausal status, especially in women under 45 or those with unclear symptoms 1.
  • The timing of hormone tests matters, as levels can fluctuate during perimenopause, so a single test may not be definitive and might need to be repeated.
  • Other hormones that might be measured include anti-Müllerian hormone (AMH) and occasionally thyroid-stimulating hormone (TSH) to rule out thyroid disorders that can mimic menopausal symptoms.
  • Testing is most useful in women with therapy-induced amenorrhea, where ovarian function may still be intact or resume despite anovulation/amenorrhea after chemotherapy, and in women considering certain treatments like aromatase inhibitors 1.

Interpretation of Laboratory Results

  • Elevated FSH levels (>30 IU/L) and decreased estradiol levels are typically seen in menopause 1.
  • A single test may not be definitive, and results should be interpreted in the context of clinical symptoms and menstrual history.
  • Serial measurement of FSH and/or estradiol may be needed to ensure postmenopausal status in certain situations, such as in women with therapy-induced amenorrhea 1.

From the Research

Laboratory Tests for Menopause

  • The diagnosis of menopause is typically a clinical diagnosis, made retrospectively, based on a 12-month period of consecutive amenorrhoea in a compatible age group (after 45 years of age) 2.
  • No hormonal dosage or imaging is indicated to make a diagnosis of menopause in a classic situation 2.
  • However, in certain situations, such as women with a history of hysterectomy, a repeat FSH≥40 combined with low estradiol (<20pg/ml) at least 3 months after the procedure could be a diagnostic orientation towards menopausal status 2.

Recommended Laboratory Tests

  • FSH (Follicle-Stimulating Hormone) test: to confirm menopausal status in women with a history of hysterectomy or other complex clinical situations 2, 3.
  • Estradiol test: to confirm low estrogen levels in women with a history of hysterectomy or other complex clinical situations 2, 3.

Interpretation of Laboratory Results

  • Elevated FSH levels (≥40) and low estradiol levels (<20pg/ml) may indicate menopausal status in women with a history of hysterectomy or other complex clinical situations 2, 3.
  • However, it is essential to consider the clinical context and medical history of the patient when interpreting laboratory results 2, 4.

Special Considerations

  • Women using hormonal contraception or with a history of cancer may require special consideration when diagnosing menopause 2, 5.
  • In these cases, laboratory tests may not be recommended, and clinical judgment should be used to determine the best course of action 2, 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Early menopause].

Journal de gynecologie, obstetrique et biologie de la reproduction, 1997

Research

NIH State-of-the-Science Conference Statement on management of menopause-related symptoms.

NIH consensus and state-of-the-science statements, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.